CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT06804057
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blood Collection — OTHER
    Blood will be collected for the subjects who are willing to participate in the optional biorepository

Study Details

Prospective, observational registry for subjects with SLE under the care of a rheumatology provider. Longitudinal data are collected from both subjects and their treating rheumatology provider during routine clinical encounters using a structured and standardized data collection method.

Key Dates

Start date
Sep 26, 2024
Status verified
Jan 2026
Primary completion
Dec 31, 2099
Completion
Dec 31, 2099

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

SLE epidemiology and presentation, [ Time Frame: Every 6 months for 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitasWalthamMassachusetts02451
Cathy Cheney
[email protected]
508-408-5435

Find similar trials in Waltham, MA

By condition
Lupus (SLE)
By specialty
RheumatologyAutoimmune disease
By research site
CorEvitas· Waltham, MA

Related Studies